Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$567,578
-$1,280,116 QoQ
Shares Held
433,266
-63.0% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 130 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. LCTX ranks #282 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in LCTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $567,578 433,266
2026-03-31 $1,847,694 1,169,427
2025-12-31 $2,402,705 1,438,746
2025-09-30 $244,501 144,676
2025-06-30 $163,971 180,189
2025-03-31 $157,546 350,103
2024-12-31 $192,532 385,066
2024-09-30 $222,243 244,224
2024-06-30 $164,584 164,584
2024-03-31 $39,299 26,554
2023-12-31 $40,817 37,447
2023-09-30 $35,269 29,890
2023-06-30 $37,393 26,520
2023-03-31 $419,653 279,769
2022-12-31 $16,472 14,079
2022-09-30 $17,484 15,473
2022-06-30 $126,666 80,169
2022-03-31 $196,244 127,432
2021-12-31 $241,714 98,659
2021-09-30 $244,618 97,071
2021-06-30 $38,115 13,374
2021-03-31 $466,799 198,638
2020-06-30 $105,181 120,899
2020-03-31 $54,539 65,710